miR-181a Mediates Inflammatory Gene Expression After Intracerebral Hemorrhage: An Integrated Analysis of miRNA-seq and mRNA-seq in a Swine ICH Model

被引:0
|
作者
Kyle B. Walsh
Kip D. Zimmerman
Xiang Zhang
Stacie L. Demel
Yu Luo
Carl D. Langefeld
Eric Wohleb
Grant Schulert
Daniel Woo
Opeolu Adeoye
机构
[1] University of Cincinnati Gardner Neuroscience Institute,Department of Emergency Medicine
[2] University of Cincinnati,Department of Biostatistics and Data Science
[3] Wake Forest University School of Medicine,Department of Environmental Health
[4] University of Cincinnati,Department of Neurology and Rehabilitation Medicine
[5] University of Cincinnati,Department of Molecular Genetics, Biochemistry, and Microbiology
[6] University of Cincinnati,Department of Pharmacology and Systems Physiology
[7] University of Cincinnati,Division of Pediatric Rheumatology
[8] University of Cincinnati Neurobiology Research Center,Department of Emergency Medicine
[9] Cincinnati Children’s Hospital Medical Center,undefined
[10] Washington University in St. Louis,undefined
来源
关键词
Stroke; Intracerebral hemorrhage; Transcriptomics; RNA-seq; Inflammation; Preclinical models;
D O I
暂无
中图分类号
学科分类号
摘要
Intracerebral hemorrhage (ICH) is a severe neurological disorder with no proven treatment. Inflammation after ICH contributes to clinical outcomes, but the relevant molecular mechanisms remain poorly understood. In studies of peripheral leukocyte counts and mRNA-sequencing (mRNA-seq), our group previously reported that monocytes and Interleukin-8 (IL-8) were important contributors to post-ICH inflammation. microRNA (miRNA) are powerful regulators of gene expression and promising therapeutic targets. We now report findings from an integrated analysis of miRNA-seq and mRNA-seq in peripheral blood mononuclear cells (PBMCs) from a swine ICH model. In 10 pigs, one PBMC sample was collected immediately prior to ICH induction and a second 6 h later; miRNA-seq and mRNA-seq were completed for each sample. An aggregate score calculation determined which miRNA regulated the differentially expressed mRNA. Networks of molecular interactions were generated for the combined miRNA/target mRNA. A total of 227 miRNA were identified, and 46 were differentially expressed after ICH (FDR < 0.05). The anti-inflammatory miR-181a was decreased post-ICH, and it was the most highly connected miRNA in the miRNA/mRNA bioinformatic network analysis. miR-181a has interconnected pathophysiology with IL-8 and monocytes; in prior studies, we found that IL-8 and monocytes contributed to post-ICH inflammation and ICH clinical outcome, respectively. miR-181a was a significant mediator of post-ICH inflammation and is promising for further study, including as a potential therapeutic target. This investigation also demonstrated feasible methodology for miRNA-seq/mRNA-seq analysis in swine that is innovative, and with unique challenges, compared with transcriptomics research in more established species.
引用
收藏
页码:1802 / 1814
页数:12
相关论文
共 23 条
  • [21] Assessment on the lung injury of mice posed by airborne PM2.5 collected from developing area in China and associated molecular mechanisms by integrated analysis of mRNA-seq and miRNA-seq
    Dai, Shuiping
    Wang, Zhenglu
    Yang, Ying
    Guo, Tingting
    Li, Weimin
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2021, 224
  • [22] Analyses of mRNA-seq and miRNA-seq of the brain reveal the sex differences of gene expression and regulation before and during gonadal differentiation in 17β-estradiol or 17α-methyltestosterone-induced olive flounder (Paralichthys olivaceus)
    Zou, Yuxia
    Wu, Zhihao
    Fan, Zhaofei
    Liang, Dongdong
    Wang, Lijuan
    Song, Zongcheng
    You, Feng
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2020, 87 (01) : 78 - 90
  • [23] Integrated Analysis of mRNA-seq and miRNA-seq to identify c-MYC, YAP1 and miR-3960 as Major Players in the Anticancer Effects of Caffeic Acid Phenethyl Ester in Human Small Cell Lung Cancer Cell Line
    Mo, Fei
    Luo, Ya
    Fan, Dian
    Zeng, Hao
    Zhao, Yunuo
    Luo, Meng
    Liu, Xiaobei
    Ma, Xuelei
    CURRENT GENE THERAPY, 2020, 20 (01) : 15 - 24